These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5166217)

  • 41. Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin.
    Serrano EE; Roye DB; Hammer RH; Wilder BJ
    Neurology; 1973 Mar; 23(3):311-7. PubMed ID: 4735181
    [No Abstract]   [Full Text] [Related]  

  • 42. Is phenytoin metabolism dose-dependent by enzyme saturation or by feedback inhibition?
    Perucca E; Makki K; Richens A
    Clin Pharmacol Ther; 1978 Jul; 24(1):46-51. PubMed ID: 657718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Editorial: Drug levels in epilepsy.
    Lancet; 1975 Aug; 2(7928):264-7. PubMed ID: 49804
    [No Abstract]   [Full Text] [Related]  

  • 44. [Daily plasma fluctuations of diphenylhydantoin in patients treated with diphenylhydantoin and sodium valproate].
    Pisani F; Di Perri R
    Acta Neurol Quad (Napoli); 1981; 42():61-3. PubMed ID: 6791452
    [No Abstract]   [Full Text] [Related]  

  • 45. Studies of diphenylhydantoin metabolism.
    Kutt H; Haynes J; McDowell F
    Trans Am Neurol Assoc; 1965; 90():265-6. PubMed ID: 5857756
    [No Abstract]   [Full Text] [Related]  

  • 46. Some causes of ineffectiveness of diphenylhydantoin.
    Kutt H; Haynes J; McDowell F
    Arch Neurol; 1966 May; 14(5):489-92. PubMed ID: 5911247
    [No Abstract]   [Full Text] [Related]  

  • 47. Therapeutic response relationship to phenobarbital and diphenylhydantoin serum and cerebrospinal fluid levels in epileptics.
    Volanschi D; Pintilie C; Florescu D; Tudor S
    Neurol Psychiatr (Bucur); 1975; 13(3):217-23. PubMed ID: 1188280
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of folic acid on phenytoin kinetics in healthy subjects.
    Furlanut M; Benetello P; Avogaro A; Dainese R
    Clin Pharmacol Ther; 1978 Sep; 24(3):294-7. PubMed ID: 688723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.
    Glazko AJ; Chang T; Baukema J; Dill WA; Goulet JR; Buchanan RA
    Clin Pharmacol Ther; 1969; 10(4):498-504. PubMed ID: 5793754
    [No Abstract]   [Full Text] [Related]  

  • 50. [Diphenylhydantoin treatment of epileptics with radioimmunological monitoring of the drug levels].
    Huber Z; Kosowicz J
    Neurol Neurochir Pol; 1982; 16(1-3):29-32. PubMed ID: 7133286
    [No Abstract]   [Full Text] [Related]  

  • 51. Interaction between vigabatrin and phenytoin.
    Rimmer EM; Richens A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):27S-33S. PubMed ID: 2757906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic failures in epileptic children due to impaired diphenylhydantoin bioavailability.
    Koren G; Brand N; Daney S; Halkin H
    Isr J Med Sci; 1982 Jun; 18(6):721-3. PubMed ID: 7107212
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of phenytoin on phenobarbital pharmacokinetics in a patient with epilepsy.
    Kuranari M; Tatsukawa H; Seike M; Saikawa T; Ashikari Y; Kodama Y; Sakata T; Takeyama M
    Ann Pharmacother; 1995 Jan; 29(1):83-4. PubMed ID: 7711354
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical pharmacokinetics of phenytoin in the dog: a reevaluation.
    Frey HH; Löscher W
    Am J Vet Res; 1980 Oct; 41(10):1635-8. PubMed ID: 6784613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy].
    Petruch F; Schüppel RV
    Arzneimittelforschung; 1974 Jul; 24(7):1023-5. PubMed ID: 4211429
    [No Abstract]   [Full Text] [Related]  

  • 56. Differential effect of cimetidine on serum concentrations of carbamazepine and phenytoin.
    Levine M; Jones MW; Sheppard I
    Neurology; 1985 Apr; 35(4):562-5. PubMed ID: 3982643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Determination of blood level of diphenylhydantoin in the treatment of epilepsy. The need for monitoring].
    Lazowski J; Radzikowska B; Zadrozyńska E
    Wiad Lek; 1977 Oct; 30(20):1613-6. PubMed ID: 930076
    [No Abstract]   [Full Text] [Related]  

  • 58. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

  • 59. In vivo interaction of anticonvulsant drugs. The mathematical correlation of plasma levels of anticonvulsant drugs in epileptic patients.
    Abarbanel J; Herishanu Y; Rosenberg P; Eylath U
    J Neurol; 1978 May; 218(2):137-44. PubMed ID: 78974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient.
    Miura H; Minagawa K
    Folia Psychiatr Neurol Jpn; 1980; 34(3):295. PubMed ID: 7216015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.